Heron Therapeutics | HRTX - Уставный капитал обыкновенных акций





Уставный капитал обыкновенных акций Изменить Дата
ALKERMES USD 166.46M 855K 2026-03
Alnylam Pharmaceuticals USD 133.44M 1.07M 2026-03
Amarin USD 20.81M 13K 2025-12
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 137.39M 1.69M 2025-12
Eisai JPY 282.11M 0 2026-03
Emergent BioSolutions USD 100K 0 2023-06
Esperion Therapeutics USD 245.22M 39.79M 2025-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Heron Therapeutics USD 188.31M 4.99M 2025-12
Insmed USD 216.52M 2.27M 2026-03
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.47B 12.72M 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Neurocrine Biosciences USD 100.6M 500K 2026-03
Omeros USD 611K 17K 2023-12
Pacira USD 39.31M 1.81M 2026-03
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Ultragenyx Pharmaceutical USD 98.3M 1.7M 2026-03
Veracyte USD 79.79M 743K 2026-03
Vertex Pharmaceuticals USD 254.2M 200K 2026-03